We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$10.1B
1-Year Est. Return
42.88%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10.3B
AUM Growth
+$309M
(+3.1%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
981
New
70
Increased
333
Reduced
365
Closed
69
Top Buys
| 1 |
AVID
Avid Technology Inc
AVID
|
+$16.3M |
| 2 |
Assured Guaranty
AGO
|
+$14.9M |
| 3 |
Crane NXT
CXT
|
+$13.8M |
| 4 |
Western Alliance Bancorporation
WAL
|
+$13.1M |
| 5 |
Bankunited
BKU
|
+$13.1M |
Top Sells
| 1 |
CIR
CIRCOR International, Inc
CIR
|
+$42.4M |
| 2 |
First Citizens BancShares
FCNCA
|
+$39.3M |
| 3 |
FRG
Franchise Group, Inc.
FRG
|
+$31.1M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$17.2M |
| 5 |
Ares Management
ARES
|
+$17.1M |
Sector Composition
| 1 | Industrials | 28.58% |
| 2 | Technology | 18.63% |
| 3 | Consumer Discretionary | 12.56% |
| 4 | Financials | 12.33% |
| 5 | Materials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
First Advantage
FA
$3.51B
| $663K | 0.01% |
43,040
-124,170
| -74% | -$1.67M |
|
|
AMWD
802
DELISTED
American Woodmark
AMWD
| $652K | 0.01% |
+8,542
| New | +$496K |
|
803
Sturm, Ruger & Co
RGR
$615M
| $652K | 0.01% |
12,302
-2,899
| -19% | -$158K |
|
|
AVTA
804
DELISTED
Avantax, Inc. Common Stock
AVTA
| $647K | 0.01% |
+28,918
| New | +$681K |
|
|
SMLR
805
DELISTED
Semler Scientific
SMLR
| $637K | 0.01% |
24,263
+887
| +4% | +$23.4K |
|
|
MAGN
806
Magnera Corp
MAGN
$455M
| $635K | 0.01% |
16,185
| – | – |
|
807
Otter Tail
OTTR
$3.78B
| $635K | 0.01% |
+8,037
| New | +$603K |
|
|
ZYXI
808
DELISTED
Zynex
ZYXI
| $629K | 0.01% |
65,558
-5,623
| -8% | -$58.4K |
|
|
PYCR
809
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $626K | 0.01% |
26,435
-340,725
| -93% | -$7.94M |
|
810
WaFd
WAFD
$2.82B
| $619K | 0.01% |
+23,341
| New | +$646K |
|
811
Cytek Biosciences
CTKB
$594M
| $617K | 0.01% |
72,280
+27,866
| +63% | +$250K |
|
812
Nu Skin
NUS
$247M
| $611K | 0.01% |
18,396
-1,163
| -6% | -$42.8K |
|
813
Theravance Biopharma
TBPH
$877M
| $611K | 0.01% |
59,009
| – | – |
|
814
Pediatrix Medical
MD
$2.04B
| $605K | 0.01% |
+42,590
| New | +$598K |
|
815
Laureate Education
LAUR
$5.65B
| $605K | 0.01% |
50,000
| – | – |
|
|
EMKR
816
DELISTED
Emcore Corp
EMKR
| $593K | 0.01% |
78,840
-285
| -0.4% | -$2.58K |
|
817
1-800-Flowers.com
FLWS
$246M
| $593K | 0.01% |
76,000
-23,842
| -24% | -$219K |
|
818
CryoPort
CYRX
$791M
| $590K | 0.01% |
34,198
| – | – |
|
|
WOW
819
DELISTED
WideOpenWest
WOW
| $584K | 0.01% |
69,215
+16,915
| +32% | +$153K |
|
820
La-Z-Boy
LZB
$1.54B
| $583K | 0.01% |
+20,347
| New | +$568K |
|
|
SCHW
821
Charles Schwab
SCHW
$179B
| $582K | 0.01% |
10,270
-4,401
| -30% | -$231K |
|
|
HOUS
822
DELISTED
Anywhere Real Estate
HOUS
| $580K | 0.01% |
86,842
-740,809
| -90% | -$4.44M |
|
|
TVRD
823
Tvardi Therapeutics
TVRD
$28.6M
| $573K | 0.01% |
5,619
| – | – |
|
824
Innovative Solutions & Support
ISSC
$336M
| $565K | 0.01% |
78,828
| – | – |
|
|
OSG
825
Octave Specialty Group
OSG
$274M
| $560K | 0.01% |
39,345
+6,527
| +20% | +$95.5K |
|
Similar funds
ACA
GI
IIM
GT
VPIM
ECM
BEI
RI